Cargando…
The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer
Pancreatic enzymes might play a pivotal role in the pathophysiology and prognosis of pancreatic cancer. The aim of this study is to investigate the lipase/amylase ratio (LAR), representing a marker previously used in the differentiation of pancreatitis, as a potential prognostic marker in pancreatic...
Autores principales: | Stotz, Michael, Barth, Dominik A., Riedl, Jakob M., Asamer, Eva, Klocker, Eva V., Kornprat, Peter, Hutterer, Georg C., Prinz, Felix, Lackner, Karoline, Stöger, Herbert, Gerger, Armin, Pichler, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408133/ https://www.ncbi.nlm.nih.gov/pubmed/32635610 http://dx.doi.org/10.3390/cancers12071798 |
Ejemplares similares
-
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: A retrospective analysis
por: Asamer, Eva, et al.
Publicado: (2018) -
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
por: Barth, Dominik Andreas, et al.
Publicado: (2020) -
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients
por: Klocker, Eva Valentina, et al.
Publicado: (2020) -
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018) -
Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
por: Riedl, Jakob Michael, et al.
Publicado: (2017)